Compounds > sulfadoxine
Page last updated: 2024-08-22

sulfadoxine and Sickle Cell Trait

sulfadoxine has been researched along with Sickle Cell Trait in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adjei, O; Kang, H; Kreuels, B; Krumkamp, R; May, J; Small, DS1
Kalilani, L; Khairallah, C; Meshnick, SR; Mwapasa, V; Patel, JC; Taylor, SM; Ter Kuile, FO; Thwai, KL1
Aidoo, MA; Kager, PA; Kolczak, MS; Kuile, FO; Lal, AA; Nahlen, BL; Oloo, AJ; Terlouw, DJ; Udhayakumar, V1
Desai, MR; Kager, PA; Kariuki, SK; Pfeiffer, CM; Shi, YP; Ter Kuile, FO; Terlouw, DJ; Wannemuehler, KA1
Aubouy, A; Deloron, P; Migot-Nabias, F1

Trials

1 trial(s) available for sulfadoxine and Sickle Cell Trait

ArticleYear
Relation between the response to iron supplementation and sickle cell hemoglobin phenotype in preschool children in western Kenya.
    The American journal of clinical nutrition, 2004, Volume: 79, Issue:3

    Topics: Anemia; Antimalarials; Child, Preschool; Dietary Supplements; Disease Susceptibility; Double-Blind Method; Drug Combinations; Female; Hemoglobins; Humans; Infant; Iron; Kenya; Malaria; Male; Phenotype; Pyrimethamine; Sickle Cell Trait; Sulfadoxine

2004

Other Studies

4 other study(ies) available for sulfadoxine and Sickle Cell Trait

ArticleYear
The causal effect of malaria on stunting: a Mendelian randomization and matching approach.
    International journal of epidemiology, 2013, Volume: 42, Issue:5

    Topics: Antimalarials; Case-Control Studies; Causality; Child Development; Child, Preschool; Cohort Studies; Drug Combinations; Female; Genetic Predisposition to Disease; Ghana; Growth Disorders; Hemoglobin A; Hemoglobin, Sickle; Heterozygote; Humans; Infant; Malaria; Male; Mendelian Randomization Analysis; Multivariate Analysis; Poisson Distribution; Pyrimethamine; Regression Analysis; Sickle Cell Trait; Sulfadoxine

2013
Absence of Association Between Sickle Trait Hemoglobin and Placental Malaria Outcomes.
    The American journal of tropical medicine and hygiene, 2016, 05-04, Volume: 94, Issue:5

    Topics: Adult; Antimalarials; Cross-Sectional Studies; Drug Combinations; Female; Genotype; Hemoglobin, Sickle; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria, Falciparum; Malawi; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Prevalence; Pyrimethamine; Real-Time Polymerase Chain Reaction; Risk Factors; Sickle Cell Trait; Sulfadoxine; Young Adult

2016
Increased efficacy of sulfadoxine-pyrimethamine in the treatment of uncomplicated falciparum malaria among children with sickle cell trait in Western Kenya.
    The Journal of infectious diseases, 2002, Dec-01, Volume: 186, Issue:11

    Topics: Animals; Antimalarials; Child, Preschool; Drug Combinations; Female; Hemoglobin A; Hemoglobin, Sickle; Humans; Infant; Kenya; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Retrospective Studies; Sickle Cell Trait; Sulfadoxine; Treatment Outcome

2002
Correlations between treatment outcome and both anti-MSP119 antibody response and erythrocyte-related genetic factors in Plasmodium falciparum malaria.
    Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2007, Volume: 7, Issue:2

    Topics: Amodiaquine; Animals; Antibodies, Protozoan; Antigens, Protozoan; Antimalarials; Child; Child, Preschool; Drug Combinations; Erythrocytes; Female; Follow-Up Studies; Gabon; Glucosephosphate Dehydrogenase; Humans; Immunoglobulin G; Infant; Kinetics; Malaria, Falciparum; Male; Merozoite Surface Protein 1; Plasmodium falciparum; Protein Subunits; Protozoan Proteins; Pyrimethamine; Sickle Cell Trait; Sulfadoxine; Treatment Outcome

2007